2017
London, UK, 05 October 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Roxwood Medical (“Roxwood”), an innovative provider of advanced...
London, UK, 05 October 2017 BTG plc (LSE: BTG), the global specialist healthcare company, provides the following update for the six months ended 30 September 2017 ahead of publication of its...
London, UK, 27 September 2017 Mirada Medical Ltd, a global medical imaging software company, has signed a three-year master service agreement with BTG plc (LSE: BTG), a global specialist...
London, UK, 20 September 2017 BTG plc (LSE: BTG), the global specialist healthcare company, announces that a Memorandum Opinion has been issued by the Court of Chancery of Delaware ruling against...
13 September 2017 BTG plc (LSE: BTG), the global specialist healthcare company, announces the inclusion of two of its oncology-related antidote products in the revised ‘Expert Consensus...
N/A, 21 August 2017 Total grant funding available for investigators has been doubled BTG plc (LSE: BTG), a global specialist healthcare company, and the Society of Interventional Oncology (SIO),...
Vancouver, Canada, 25 July 2017 BTG International Canada Inc., part of global specialist healthcare company BTG, today announced EVA Vein Care is the first clinic in Vancouver and the surrounding...
London, UK, 13 July 2017 BTG plc (LSE: BTG), the global specialist healthcare company, provides the following update ahead of its Annual General Meeting, which is being held today at 10.30am at...
Bothell, WA, 16 June 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th...
West Conshohocken, PA, 13 June 2017 A study sponsored by BTG plc (LSE: BTG), the global specialist healthcare company, has been recently published in the Annals of Emergency Medicine (AEM) that...
London, UK, 10 June 2017 BTG plc (LSE: BTG), a global specialist healthcare company, today announced the results of a pilot study evaluating the effectiveness of a digital patient engagement...
Washington, DC, 07 June 2017 The Society of Interventional Oncology (SIO), a global organization working to nurture and support interventional oncology worldwide, and global specialist healthcare...
Bothell, Washington, 22 May 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the results of the OPTALYSE PE trial, presented at the American Thoracic Society...
#, 19 May 2017 Data from a pilot study using IO Loop™ with TheraSphere® (a Y90 transarterial radioembolisation therapy) will be presented at the World Conference on Interventional Oncology BTG...
London, UK, 16 May 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announces its final results for the year ended 31 March 2017. Click here to download the results release...
London, UK, 20 April 2017 BTG plc (LSE: BTG), a global specialist healthcare company, today announced the treatment of the first patients in the EU with DC Bead LUMI™. Two patients were treated...
London, UK, 06 April 2017 BTG plc (LSE:BTG), the specialist healthcare company, provides the following update for the year ended 31 March 2017 ahead of the publication of its Final Results on 16...
SnakeBite911™ Expands Free Snake Education and Snakebite Safety App to Android Devices
West Conshohocken, PA, 07 March 2017 BTG plc (LSE:BTG), an international specialist healthcare company, today announced that SnakeBite911™, the company’s consumer-friendly app containing...
London, UK, 07 March 2017 DC Bead LUMI™ provides real-time visible, lasting confirmation of bead location during and post-embolisation of hypervascular tumours in the liver BTG plc (LSE: BTG), a...
London, UK, 27 February 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announced U.S. Food and Drug Administration 510(k) clearance has been granted to the EKOS® Control...
London, UK, 15 February 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announced a collaboration with the Society of Interventional Oncology (SIO), a global organization...
Ottawa, Canada, 26 January 2017 The only Health Canada approved microfoam for the treatment of varicose veins is now available BTG International Canada Inc., part of global specialist healthcare...
Ottawa, Canada, 26 January 2017 La seule micromousse approuvée par Santé Canada pour le traitement des varices est maintenant sur le marché BTG International Canada Inc., qui fait partie de...
London UK, 09 January 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announced the first patients diagnosed with Pulmonary Embolism (PE) to be treated in Hong Kong using...